Cell lines were established which produced high titers (_ 106 infectious units per ml) of amphotropic, replication-defective recombinant retroviruses which transduced sequences encoding either human purine nucleoside phosphorylase (PNP) or adenosine deaminase (ADA). These viruses also contained a human hypoxanthine phosphoribosyltransferase gene as a selectable marker and a mouse metallothionein promoter (MMP) sequence just upstream from the PNP or ADA genes. Virus structure was maintained through the replication cycle if a short (216-base pair) MMP sequence was used. However, the use of a longer (1,834-base pair) MMP sequence resulted in the deletion of a significant portion of the recombinant virus genome, including the transcriptional regulatory elements of the MMP sequence. Northern analysis indicated a predominance of genome length transcripts in cells infected with deleted virus. The demonstration of substantial human PNP or ADA activity in virus-infected mouse fibroblasts by isozyme analysis suggested that active gene product was translated from either spliced or bicistronic message. The deleted ADA and PNP viruses were introduced into mouse hematopoietic stem cells by cocultivating freshly explanted bone marrow with virus producer cells. The infected marrow cells were injected into irradiated, syngeneic recipient mice, and the presence of integrated ADA or PNP proviral sequences was demonstrated in the DNA of spleen colonies by Southern analysis. Failure of these integrated proviral sequences to express active, human isozyme in spleen colony tissue indicated the existence of some regulatory constraint not active in cultured mouse cells.Purine nucleoside phosphorylase (PNP) and adenosine deaminase (ADA) are enzymes of purine metabolism, the absence of which in humans results in immunodeficiency disease. A severe combined immunodeficiency is associated with the lack of ADA activity (13), and a T-cell immunodeficiency is associated with the lack of PNP activity (12). Both conditions are recessive and autosomally inherited, and afflicted individuals suffer from opportunistic infections that lead to death early in childhood. The metabolic basis of these diseases has been studied intensively (see references 22 and 27 for reviews). Although a number of hypotheses have been proposed to explain the specific toxicity of these conditions to immune cells, there is much evidence that in the absence of one of these enzyme activities, deoxynucleoside substrates accumulate, resulting in unbalanced deoxynucleoside triphosphate pools, feedback inhibition of ribonucleotide reductase, and limited DNA synthesis which does not support an immunoproliferative response (22,27,46).The availability of cloned ADA and PNP coding sequences (14, 48) and progress in gene transfer technology (3,52) have led to the suggestion that the ADA-and PNPassociated immunodeficiencies might be reasonable candidates for initial attempts at human gene therapy (1,33). To * Corresponding author.